NCT07034157 A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
| NCT ID | NCT07034157 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Anzhen Hospital |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-06-09 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational cohort study aims to investigate the prevalence and clinical significance of head and neck arterial stenosis in patients with coronary artery disease (CAD) undergoing or scheduled for percutaneous coronary intervention (PCI). Using Doppler ultrasound as the primary screening tool, the study will assess the degree of stenosis and evaluate the impact of different combined treatment strategies on patient outcomes. The research will provide real-world evidence to optimize integrated care approaches for patients with comorbid cardiovascular and cerebrovascular diseases.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥18 years; 2. Patients with coronary artery disease scheduled to undergo elective percutaneous coronary intervention (PCI) on the following day. Exclusion Criteria: 1. The expected survival is less than 1 years; 2. Simultaneously merge other serious diseases;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07034157 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07034157 currently recruiting?
Yes, NCT07034157 is actively recruiting participants. Contact the research team at huoxiaochuan@126.com for enrollment information.
Where is the NCT07034157 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07034157 clinical trial?
NCT07034157 is sponsored by Beijing Anzhen Hospital. The trial plans to enroll 1,000 participants.